{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:10:29Z","timestamp":1784196629467,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022MH311"],"award-info":[{"award-number":["ZR2022MH311"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2023ZD41"],"award-info":[{"award-number":["ZR2023ZD41"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373043"],"award-info":[{"award-number":["82373043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00937-5","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:05:11Z","timestamp":1779095111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["m6A-modificated Linc00707 promotes the progression of TNBC via U2AF2-mediated alternative splicing of ATG4B"],"prefix":"10.1186","volume":"31","author":[{"given":"Hongli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonggao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"7767","key":"937_CR1","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-019-1380-3","volume":"572","author":"F Bertucci","year":"2019","unstructured":"Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, et al. Author correction: genomic characterization of metastatic breast cancers. Nature. 2019;572(7767):E7.","journal-title":"Nature"},{"issue":"6","key":"937_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","volume":"27","author":"N Howlader","year":"2018","unstructured":"Howlader N, Cronin KA, Kurian AW, Andridge R. Differences in breast cancer survival by molecular subtypes in the united states. Cancer Epidemiol Biomarkers Prev. 2018;27(6):619\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"937_CR3","doi-asserted-by":"crossref","unstructured":"Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International consensus guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019;30 (10):1541\u201357.","DOI":"10.1093\/annonc\/mdz235"},{"issue":"7","key":"937_CR4","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1016\/S1470-2045(19)30158-5","volume":"20","author":"L Pusztai","year":"2019","unstructured":"Pusztai L, Foldi J, Dhawan A, DiGiovanna MP, Mamounas EP. Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers. Lancet Oncol. 2019;20(7):e390\u20136.","journal-title":"Lancet Oncol"},{"issue":"12","key":"937_CR5","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/0008-5472.CAN-21-3714","volume":"82","author":"S Singh","year":"2022","unstructured":"Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, et al. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer Res. 2022;82(12):2281\u201397.","journal-title":"Cancer Res"},{"key":"937_CR6","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen H, Mo H, Zhao N, Sun X, Liu B, et al. Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell. 2025;43 (3):446\u201363 e7.","DOI":"10.1016\/j.ccell.2025.01.007"},{"issue":"1","key":"937_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"key":"937_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","volume":"497","author":"X Bai","year":"2021","unstructured":"Bai X, Ni J, Beretov J, Graham P, Li Y. Triple-negative breast cancer therapeutic resistance: where is the Achilles\u2019 heel? Cancer Lett. 2021;497:100\u201311.","journal-title":"Cancer Lett"},{"issue":"17","key":"937_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207257","volume":"10","author":"T Jiang","year":"2023","unstructured":"Jiang T, Zhu J, Jiang S, Chen Z, Xu P, Gong R, et al. Targeting lncRNA DDIT4-AS1 sensitizes triple negative breast cancer to chemotherapy via suppressing of autophagy. Adv Sci (Weinh). 2023;10(17):e2207257.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"937_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s10020-022-00551-z","volume":"28","author":"X Wang","year":"2022","unstructured":"Wang X, Li Q, He S, Bai J, Ma C, Zhang L, et al. LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation. Mol Med. 2022;28(1):126.","journal-title":"Mol Med"},{"issue":"5","key":"937_CR11","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/nar\/gkad1242","volume":"52","author":"R Vaid","year":"2024","unstructured":"Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, et al. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Res. 2024;52(5):2648\u201371.","journal-title":"Nucleic Acids Res"},{"key":"937_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1146\/annurev-genet-112414-055205","volume":"49","author":"VH Meller","year":"2015","unstructured":"Meller VH, Joshi SS, Deshpande N. Modulation of chromatin by noncoding RNA. Annu Rev Genet. 2015;49:673\u201395.","journal-title":"Annu Rev Genet"},{"key":"937_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.813963","volume":"10","author":"Q Yao","year":"2022","unstructured":"Yao Q, Li Z, Chen D. Review of LINC00707: a novel LncRNA and promising biomarker for human diseases. Front Cell Dev Biol. 2022;10:813963.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"937_CR14","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1080\/21655979.2021.1973874","volume":"12","author":"J Shao","year":"2021","unstructured":"Shao J, Zhang B, Kuai L, Li Q. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients. Bioengineered. 2021;12(1):6186\u2013200.","journal-title":"Bioengineered"},{"issue":"1","key":"937_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41420-024-01906-7","volume":"10","author":"H Li","year":"2024","unstructured":"Li H, Liu Q, Hu Y, Yin C, Zhang Y, Gao P. Linc00707 regulates autophagy and promotes the progression of triple negative breast cancer by activation of PI3K\/AKT\/mTOR pathway. Cell Death Discov. 2024;10(1):138.","journal-title":"Cell Death Discov"},{"key":"937_CR16","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.2147\/OTT.S198140","volume":"12","author":"H Zhu","year":"2019","unstructured":"Zhu H, He G, Wang Y, Hu Y, Zhang Z, Qian X. Long intergenic noncoding RNA 00707 promotes colorectal cancer cell proliferation and metastasis by sponging miR-206. Onco Targets Ther. 2019;12:4331\u201340.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"937_CR17","first-page":"1439","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang H, Luan H, Zhan T, Liu X, Song J, Dai H. Long non-coding RNA LINC00707 acts as a competing endogenous RNA to enhance cell proliferation in colorectal cancer. Exp Ther Med. 2020;19(2):1439\u201347.","journal-title":"Exp Ther Med"},{"issue":"1","key":"937_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13287-019-1161-9","volume":"10","author":"B Jia","year":"2019","unstructured":"Jia B, Wang Z, Sun X, Chen J, Zhao J, Qiu X. Long noncoding RNA LINC00707 sponges miR-370-3p to promote osteogenesis of human bone marrow-derived mesenchymal stem cells through upregulating WNT2B. Stem Cell Res Ther. 2019;10(1):67.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"937_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-021-03432-1","volume":"12","author":"S Yu","year":"2021","unstructured":"Yu S, Ruan X, Liu X, Zhang F, Wang D, Liu Y, et al. HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707\/miR-651-3p\/SP2 axis. Cell Death Dis. 2021;12(2):153.","journal-title":"Cell Death Dis"},{"issue":"22","key":"937_CR20","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1182\/blood.2023021287","volume":"143","author":"G Liu","year":"2024","unstructured":"Liu G, Kim J, Nguyen N, Zhou L, Dean A. Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape modulation. Blood. 2024;143(22):2300\u201313.","journal-title":"Blood"},{"key":"937_CR21","doi-asserted-by":"crossref","unstructured":"Deforzh E, Kharel P, Zhang Y, Karelin A, El Khayari A, Ivanov P, et al. HOXDeRNA activates a cancerous transcription program and super enhancers via genome-wide binding. Mol Cell. 2024;84 (20):3950\u201366 e6.","DOI":"10.1016\/j.molcel.2024.09.018"},{"issue":"1","key":"937_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176.","journal-title":"Mol Cancer"},{"issue":"3","key":"937_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"937_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"937_CR25","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660-77 e10.","journal-title":"Mol Cell"},{"issue":"1","key":"937_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106.","journal-title":"Mol Cancer"},{"issue":"1","key":"937_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, Chen D, Yang B, He B, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer. 2019;18(1):127.","journal-title":"Mol Cancer"},{"issue":"8","key":"937_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-021-04016-9","volume":"12","author":"ZX Jiang","year":"2021","unstructured":"Jiang ZX, Wang YN, Li ZY, Dai ZH, He Y, Chu K, et al. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging. Cell Death Dis. 2021;12(8):744.","journal-title":"Cell Death Dis"},{"issue":"1","key":"937_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-024-46357-x","volume":"15","author":"T Zhuang","year":"2024","unstructured":"Zhuang T, Chen MH, Wu RX, Wang J, Hu XD, Meng T, et al. ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice. Nat Commun. 2024;15(1):1995.","journal-title":"Nat Commun"},{"issue":"1","key":"937_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"937_CR31","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1080\/15548627.2022.2046448","volume":"18","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang H, Chen H, Li H, Xu P, Liu B, et al. ATF3 -activated accelerating effect of LINC00941\/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1\/HuR in pulmonary fibrosis. Autophagy. 2022;18(11):2636\u201355.","journal-title":"Autophagy"},{"issue":"1","key":"937_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tcb.2014.09.001","volume":"25","author":"CM Kenific","year":"2015","unstructured":"Kenific CM, Debnath J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol. 2015;25(1):37\u201345.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"937_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"38","key":"937_CR34","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/onc.2016.67","volume":"35","author":"P Zhang","year":"2016","unstructured":"Zhang P, Feng S, Liu G, Wang H, Fu A, Zhu H, et al. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation. Oncogene. 2016;35(38):5056\u201369.","journal-title":"Oncogene"},{"issue":"11","key":"937_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nsmb.2906","volume":"21","author":"C Shao","year":"2014","unstructured":"Shao C, Yang B, Wu T, Huang J, Tang P, Zhou Y, et al. Mechanisms for U2AF to define 3\u2019 splice sites and regulate alternative splicing in the human genome. Nat Struct Mol Biol. 2014;21(11):997\u20131005.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"937_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13058-024-01817-6","volume":"26","author":"W Zhang","year":"2024","unstructured":"Zhang W, Song X, Jin Z, Zhang Y, Li S, Jin F, et al. U2AF2-SNORA68 promotes triple-negative breast cancer stemness through the translocation of RPL23 from nucleoplasm to nucleolus and c-Myc expression. Breast Cancer Res. 2024;26(1):60.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"937_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2017.11.003","volume":"43","author":"J Lichti","year":"2018","unstructured":"Lichti J, Gallus C, Glasmacher E. Immune responses-transcriptional and post-transcriptional networks pass the baton. Trends Biochem Sci. 2018;43(1):1\u20134.","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"937_CR38","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252\u201366.","journal-title":"Mol Cell"},{"issue":"2","key":"937_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"937_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"IM Dykes","year":"2017","unstructured":"Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15(3):177\u201386.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"2","key":"937_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13520","volume":"168","author":"J Wang","year":"2023","unstructured":"Wang J, Gong R, Zhao C, Lei K, Sun X, Ren H. Human FOXP3 and tumour microenvironment. Immunology. 2023;168(2):248\u201355.","journal-title":"Immunology"},{"issue":"4","key":"937_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.it.2025.02.010","volume":"46","author":"S Luo","year":"2025","unstructured":"Luo S, Larson JH, Blazar BR, Abdi R, Bromberg JS. Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function. Trends Immunol. 2025;46(4):324\u201337.","journal-title":"Trends Immunol"},{"issue":"3","key":"937_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12016-016-8572-5","volume":"52","author":"Z Vadasz","year":"2017","unstructured":"Vadasz Z, Toubi E. FoxP3 expression in macrophages, cancer, and B cells-is it real? Clin Rev Allergy Immunol. 2017;52(3):364\u201372.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"937_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q, Tao Q. WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27(1):51.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"937_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"issue":"17","key":"937_CR46","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1093\/cvr\/cvae239","volume":"120","author":"JF Ding","year":"2024","unstructured":"Ding JF, Tu B, Song K, Liu ZY, Lin LC, Liu ZY, et al. Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification. Cardiovasc Res. 2024;120(17):2236\u201348.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"937_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01066-6","volume":"14","author":"F Jiang","year":"2021","unstructured":"Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, et al. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. J Hematol Oncol. 2021;14(1):54.","journal-title":"J Hematol Oncol"},{"issue":"23","key":"937_CR48","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1016\/j.molcel.2024.10.033","volume":"84","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Corovic M, Hoch-Kraft P, Meiser N, Mesitov M, Kortel N, et al. m6A sites in the coding region trigger translation-dependent mRNA decay. Mol Cell. 2024;84(23):4576-93 e12.","journal-title":"Mol Cell"},{"issue":"8","key":"937_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206694120","volume":"120","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Lu YX, Liu F, Sang L, Shi C, Xie S, et al. LncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. Proc Natl Acad Sci U S A. 2023;120(8):e2206694120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"937_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-023-02847-2","volume":"42","author":"F Wang","year":"2023","unstructured":"Wang F, Hu Y, Wang H, Hu P, Xiong H, Zeng Z, et al. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. J Exp Clin Cancer Res. 2023;42(1):267.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"937_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18106","volume":"28","author":"M Wei","year":"2024","unstructured":"Wei M, Lu L, Ma J, Luo Z, Tan X, Wang J. LINC00707 impairs the natural killer cell antitumour activity in hepatocellular carcinoma through decreasing YTHDF2 stability. J Cell Mol Med. 2024;28(5):e18106.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"937_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, et al. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9(1):179\u201395.","journal-title":"Theranostics"},{"issue":"6","key":"937_CR53","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.molcel.2022.02.025","volume":"82","author":"G Biancon","year":"2022","unstructured":"Biancon G, Joshi P, Zimmer JT, Hunck T, Gao Y, Lessard MD, et al. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies. Mol Cell. 2022;82(6):1107-22 e7.","journal-title":"Mol Cell"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00937-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:01:52Z","timestamp":1784196112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00937-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00937-5","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients in this study provided written informed consent for sample collection and data analyses. The research was approved by the ethics committee of Shandong Second Medical University (approval no. 2017050) and based on the ethical principles for medical research involving human subjects of the Helsinki Declaration. Animal experiments were approved by the Animal Experimental Research Ethics Committee of Shandong Second Medical University and conducted according to its guidelines (approval no. 2023SDL311). This study conforms to the Declaration of Helsinki of the World Medical Association.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}